2016
DOI: 10.5551/jat.33449
|View full text |Cite
|
Sign up to set email alerts
|

The Relationship between Very High Levels of Serum High-Density Lipoprotein Cholesterol and Cause-Specific Mortality in a 20-Year Follow-Up Study of Japanese General Population

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
59
2
1

Year Published

2016
2016
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 49 publications
(64 citation statements)
references
References 38 publications
(32 reference statements)
1
59
2
1
Order By: Relevance
“…[4][5][6][7][8] However, some studies showed that high levels of HDL-C are paradoxically associated with high mortality and vascular events. [9][10][11] In clinical trials, elevating HDL-C levels by inhibition of CETP failed to decrease cardiovascular disease. [13][14][15] The first CETP inhibitor, torcetrapib, increased the risk of mortality and morbidity of cardiovascular disease rather than reducing the risk of cardiovascular events, while torcetrapib increased HDL-C levels.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…[4][5][6][7][8] However, some studies showed that high levels of HDL-C are paradoxically associated with high mortality and vascular events. [9][10][11] In clinical trials, elevating HDL-C levels by inhibition of CETP failed to decrease cardiovascular disease. [13][14][15] The first CETP inhibitor, torcetrapib, increased the risk of mortality and morbidity of cardiovascular disease rather than reducing the risk of cardiovascular events, while torcetrapib increased HDL-C levels.…”
Section: Discussionmentioning
confidence: 99%
“…31 All participants were divided into 4 groups according to the definitions used in a previous study in Japan: low HDL-C (,40 mg/dL), moderate HDL-C (40-59 mg/dL), high HDL-C (60-79 mg/dL), and extremely high HDL-C ($80 mg/dL). 9,32 The ethical committees of the participating institutions approved the study protocol. The study was executed in accordance with the Good Clinical Practice guidelines.…”
Section: Subjectsmentioning
confidence: 99%
See 1 more Smart Citation
“…Представленные данные не дают возможности определить верхний порог концентрации ХС ЛВП, выше которого происходит ухудшение результатов, хотя по данным ряда исследователей высокий уровень ХС ЛВП не только обладает превентивным действием, но, наоборот, может способствовать ухудшению состояния (>2,0 ммоль/л). Близкие результаты получены японскими авторами, которые в течение 20 лет наблюдали 7019 чел., при этом уровень ХС ЛВП не был ассоциирован с общей смертностью, смертностью от мозгового инсульта; высокий уровень ХС ЛВП (1,7 ммоль/л) был ассоциирован с протекцией ИБС, однако очень высокий уровень ХС ЛВП (≥2,0 ммоль/л) не сопровождался снижением сердечно-сосудистых событий [9].…”
Section: инфаркт миокардаunclassified
“…Although subjects with very high HDL-C level are frequently observed in Japan, little is known about the atherogenicity in patients with very high HDL-C level in Japanese dwellers. In the current study, Hirata et al investigated the relationship between serum HDL categories including the very high HDL-C level ( 80 mg/dL) and all-cause/CV mortality for a long observational period from 10 to 20 years using the national cohort, surveillance study of "NIPPON DATA90" 3) . HDL-C level was not associated with all-cause mortality or stroke.…”
Section: See Article Vol 23: 800-809mentioning
confidence: 99%